The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease

被引:83
|
作者
Zhang, Xingyu [1 ]
Fu, Zhihui [1 ]
Meng, Lanxia [1 ]
He, Mingyang [1 ]
Zhang, Zhentao [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; beta-amyloid; aggregation; age; diabetes; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN APO E4; A-BETA; OXIDATIVE STRESS; HEAD-INJURY; DIABETES-MELLITUS; PRECURSOR PROTEIN; MOUSE MODEL; INFLAMMATORY S100A9; MICROGLIAL RESPONSE;
D O I
10.3389/fnagi.2018.00359
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is characterized by the development of amyloid plaques and neurofibrillary tangles (NFTs) consisting of aggregated beta-amyloid (A beta) and tau, respectively. The amyloid hypothesis has been the predominant framework for research in AD for over two decades. According to this hypothesis, the accumulation of A beta in the brain is the primary factor initiating the pathogenesis of AD. However, it remains elusive what factors initiate A beta aggregation. Studies demonstrate that AD has multiple causes, including genetic and environmental factors. Furthermore, genetic factors, many age-related events and pathological conditions such as diabetes, traumatic brain injury (TBI) and aberrant microbiota also affect the aggregation of A beta. Here we provide an overview of the age-related early events and other pathological processes that precede A beta aggregation.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Polyoxometalates as Inhibitors of the Aggregation of Amyloid β Peptides Associated with Alzheimer's Disease
    Geng, Jie
    Li, Meng
    Ren, Jinsong
    Wang, Enbo
    Qu, Xiaogang
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (18) : 4184 - 4188
  • [22] Disrupting β-amyloid aggregation for Alzheimer disease treatment
    Estrada, L. D.
    Soto, C.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (01) : 115 - 126
  • [23] Tyrosine Photophysics During the Early Stages of β-Amyloid Aggregation Leading to Alzheimer's
    Rolinski, Olaf J.
    Wellbrock, Thorben
    Birch, David J. S.
    Vyshemirsky, Vladislav
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2015, 6 (15): : 3116 - 3120
  • [24] Alzheimer's Disease: A Molecular View of β-Amyloid Induced Morbific Events
    Asik, Rajmohamed Mohamed
    Suganthy, Natarajan
    Aarifa, Mohamed Asik
    Kumar, Arvind
    Szigeti, Krisztian
    Mathe, Domokos
    Gulyas, Balazs
    Archunan, Govindaraju
    Padmanabhan, Parasuraman
    BIOMEDICINES, 2021, 9 (09)
  • [25] Time between milestone events in the Alzheimer's disease amyloid cascade
    Insel, Philip S.
    Donohue, Michael C.
    Berron, David
    Hansson, Oskar
    Mattsson-Carlgren, Niklas
    NEUROIMAGE, 2021, 227
  • [26] β-amyloid burden in Alzheimer's and Pick's disease:: What is the relationship to α-synuclein aggregation?
    Lippa, CE
    Mori, H
    ANNALS OF NEUROLOGY, 2004, 56 : S48 - S48
  • [27] Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease
    Defelice, FG
    Ferreira, ST
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2002, 74 (02): : 265 - 284
  • [28] Phenylethanoids can Modulate Amyloid-β Aggregation Associated with Alzheimer's Disease
    Vance, S. Zeb
    Pate, Kayla
    Moore, Colman
    Moss, Melissa
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 219A - 219A
  • [29] Evidence of a role for agrin in β-amyloid (Aβ) aggregation and persistence in Alzheimer's disease.
    Cotman, SL
    Halfter, W
    Cole, GJ
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 60A - 60A
  • [30] Identification of β-aminopyrrolidine containing peptides as β-amyloid aggregation inhibitors for Alzheimer's disease
    Preetham, Habbanakuppe D.
    Muddegowda, Umashankara
    Kumar, Kothanahally S. Sharath
    Rangappa, Shobith
    Rangappa, Kanchugarakoppal S.
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28 (06)